Financial reports
10-K
2023 FY
Annual report
27 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
16 Jun 23
NT 10-Q
Notice of late quarterly filing
12 May 23
10-K
2022 FY
Annual report
27 Apr 23
NT 10-K
Notice of late annual filing
31 Mar 23
10-Q
2022 Q3
Quarterly report
6 Jan 23
NT 10-Q
Notice of late quarterly filing
14 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
Current reports
8-K
Regulation FD Disclosure
28 Mar 24
8-K
Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023
27 Mar 24
8-K
Entry into a Material Definitive Agreement
6 Mar 24
8-K
Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023
1 Feb 24
8-K
Entry into a Material Definitive Agreement
31 Jan 24
8-K/A
Financial Statements and Exhibits
25 Jan 24
8-K
Entry into a Material Definitive Agreement
11 Jan 24
8-K
Entry into a Material Definitive Agreement
26 Dec 23
8-K
Entry into a Material Definitive Agreement
12 Dec 23
8-K
Entry into a Material Definitive Agreement
7 Dec 23
Registration and prospectus
D
$2.88 mm in debt / options / securities to be acquired, sold $2.88 mm, 14 investors
10 Oct 23
424B3
Prospectus supplement
14 Aug 23
S-1/A
IPO registration (amended)
10 Aug 23
S-1/A
IPO registration (amended)
3 Aug 23
S-1
IPO registration
7 Jul 23
D
$1.38 mm in debt / options, sold $1.38 mm, 4 investors
6 Mar 23
D
$2.31 mm in equity / debt / options, sold $2.31 mm, 8 investors
3 Feb 23
25-NSE
Exchange delisting
27 Oct 22
424B3
Prospectus supplement
30 Sep 22
S-1
IPO registration
23 Sep 22
Proxies
DEF 14A
Definitive proxy
29 Aug 23
PRER14A
Preliminary revised proxy
18 Aug 23
PRE 14A
Preliminary proxy
10 Aug 23
DEF 14A
Definitive proxy
1 May 23
DEFA14A
Additional proxy soliciting materials
16 Feb 23
DEF 14A
Definitive proxy
15 Feb 23
PRE 14A
Preliminary proxy
26 Jan 23
DEFA14A
Additional proxy soliciting materials
7 Apr 22
DEFA14A
Additional proxy soliciting materials
7 Apr 22
DEFA14A
Additional proxy soliciting materials
6 Apr 22
Other
EFFECT
Notice of effectiveness
15 Aug 23
CORRESP
Correspondence with SEC
10 Aug 23
CORRESP
Correspondence with SEC
3 Aug 23
UPLOAD
Letter from SEC
19 Jul 23
EFFECT
Notice of effectiveness
3 Oct 22
CORRESP
Correspondence with SEC
28 Sep 22
UPLOAD
Letter from SEC
28 Sep 22
EFFECT
Notice of effectiveness
6 Aug 21
CORRESP
Correspondence with SEC
3 Aug 21
UPLOAD
Letter from SEC
3 Aug 21
Ownership
SC 13G/A
CVI Investments, Inc.
14 Feb 24
4
Yan Zhang
12 Jan 24
4
Kim P. Kamdar
22 Dec 23
5
Justin J. File
8 May 23
4
SAUNDRA L PELLETIER
26 Apr 23
3
Yan Zhang
26 Apr 23
SC 13G/A
CVI Investments, Inc.
14 Feb 23
SC 13G/A
Cox Todd Stewart
10 Aug 22
3
Jenny C. Yip
8 Aug 22
SC 13G
Cox Todd Stewart
19 Jul 22